Peters, R. (2018). Putting Viral Clearance Capabilities to the Test: Process understanding and careful assessment of risks are essential in developing viral clearance programs. BioPharm International, 31(5), 18-21.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Peters, Rita. "Putting Viral Clearance Capabilities to the Test: Process Understanding and Careful Assessment of Risks Are Essential in Developing Viral Clearance Programs."
BioPharm International 31, no. 5 (2018): 18-21.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Peters, Rita. "Putting Viral Clearance Capabilities to the Test: Process Understanding and Careful Assessment of Risks Are Essential in Developing Viral Clearance Programs."
BioPharm International, vol. 31, no. 5, 2018, pp. 18-21.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.